Abstract
An antigen identified by two monoclonal anti-colorectal cancer antibodies was studied in sera of 85 patients who had a resection of their primary colorectal cancer. Preoperative and postoperative serum samples and sera collected every 3 months for at least 1 year were included in this study. The levels of these antigens were compared to the carcinoembryonic antigen (CEA) levels. Sixty-six patients had at least one antigen elevated in the preoperative period. Malignancy recurred in 10 patients. In 8 of these the recurrence could have been predicted by the persistence or rise in antigen levels 3 to 18 months prior to the detection of the recurrence by current clinical methods. The data suggest that the assays for these antigens are valuable prognostic aids for making clinical therapeutic decisions and appropriately stratifying patients for clinical trials.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Old, LJ: Cancer immunology: The search for specificity—G. H. A. Clowes Memorial. Cancer Res. 41:361–375, 1981
Oettgen HF, Old LJ: Immunotherapy of colon cancer: Prospects for developing immunogenic vaccines based on autologous serological typing. Cancer 45:1218–1222, 1980
Lampson L, Levy R: A role for clonal antigens and cancer diagnosis and therapy. J Natl Cancer Inst 62:217–219, 1979
Koprowski H, Sears HF, Herlyn M, Steplewski Z: Sera from patients with adenocarcinoma of the colon inhibit binding of monoclonal antibody to colon carcinoma cells. Science 212:53–55, 1981
Herlyn M, Sears HF, Steplewski Z, Koprowski H: Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol 2:135–140, 1982
Chang TH, Steplewski Z, Sears HF, Koprowski H: Detection of monoclonal antibody-defined colorectal carcinoma antigen by solid-phase binding inhibition radioimmunoassay. Hybridoma 1:37–45, 1981
Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies: Somat Cell Genet 5:957–972, 1979
Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H: Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40:717–721, 1980
Ziola BA, Matikainen MT, Selmi A: Polystyrene balls as the solid-phase of a double-antibody radioimmunoassay for human serum albumin. J Immunol Methods 17:309–317, 1977
Javadpour N, Kim EE, DeLand FH, Salyer JR, Shah U, Goldenberg M: The role of radioimmunodetection in the management of testicular cancer. JAMA 246:45–50, 1981
Javadpour N, McIntire KR, Waldmann TA, Scardino PT, Bergman S, Anderson T: The role of the radioimmunoassay of serum alphafetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors. Urology 119:759–762, 1978
Well SA, Baylin SB, Gann DS, Farrell RE, Dilley WG, Presissig SH, Linehan WM, Cooper CW: Medullary thyroid carcinoma: Relationship of method of diagnosis to pathologic staging. Ann Surg 188:377–383, 1978
Norton J, Doppman J, Brennan M: Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87:616–622, 1980
Mach JP, Carrel S, Forni M, Ritschard J, Donath A, Alberto P: Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: A critical evaluation. N Engl J Med 303:510, 1980
Goldenberg DM, Kim EE, Deland FH: Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 40:2984–2992, 1980
Gerfo P, Herter FP: Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg 181:81–84, 1975
Herrera MA, Chu TM, Holyoke D, Mittleman A: CEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg 185:23–30, 1977
Herrera MA, Chu TM, Holyoke ED: Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 183:5–9, 1976
Martin EW, Cooperman M, King G, Rinker L, Carey LC, Minton JP: A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer. Am J Surg 137:167–169, 1979
Staab HJ, Anderer FA, Stumpf E, Fischer R: Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol 10:273–282, 1978
Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448–451, 1978
Wanebo HJ, Stearns M, Schwartz MK: Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 188:481–493, 1978
Mach JP, Jaeger PH, Bertholet MD, Ruegsbegger CH, Loosli RM, Pettavel J: Detection of recurrence of largebowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet ii:535–540, 1974
Minton JP, James KK, Hurtubise PE, Rinker L, Joyce S, Martin EW: The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation. Surg Gynecol Obstet 147:208–210, 1978
Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mithchell KF, Steplewski Z, Koprowski H: A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55–56, 1981
Steele G, Sonis S, Stelos P, Rittgers R, Zamcheck N, Finn D, Maltz J, Mayer R, Lokich J: Circulating immune complexes in patients following clinically curative resection of colorectal cancer. Surgery 83:648–654, 1978
Atkinson BF, Ernst CS, Herlyn M, Sears HF, Steplewski Z, Koprowski H: Immunoperoxidase localization of a monoclonal antibody-defined gastrointestinal monosialoganglioside (manuscript in preparation)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sears, H.F., Herlyn, M., Del Villano, B. et al. Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol 2, 141–149 (1982). https://doi.org/10.1007/BF00916898
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00916898